ArticleBlood advances2018

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase.

Sarah E Fordham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.